UPDATE: And now it’s official. Pelfrey will undergo Tommy John surgery tomorrow.
While not quite official yet, the Mets just announced that Mike Pelfrey will travel to Alabama tomorrow to see Dr. James Andrews and is expected to undergo Tommy John elbow surgery.
Pelfrey pitched well through three starts, including eight innings of one-run ball his last time out, but was diagnosed with a partially torn ulnar collateral ligament earlier this week.
Surgery would knock him out for the entire season and perhaps part of 2013 as well, likely ending his Mets career after seven years and 149 starts. He’ll be under team control via arbitration next season, but because Pelfrey is making $5.8 million this year and can only take a 20 percent pay cut he’ll almost surely be non-tendered.
The Athletic’s Ken Rosenthal reports that the Mets and free agent reliever Brad Brach have agreed on a one-year deal worth $850,000. The contract includes a player option for the 2021 season with a base salary of $1.25 million and additional performance incentives.
Brach, 33, signed as a free agent with the Cubs this past February. After posting an ugly 6.13 ERA over 39 2/3 innings, the Cubs released him in early August. The Mets picked him up shortly thereafter. Brach’s performance improved, limiting opposing hitters to six runs on 15 hits and three walks with 15 strikeouts in 14 2/3 innings through the end of the season.
While Brach will add some much-needed depth to the Mets’ bullpen, his walk rate has been going in the wrong direction for the last three seasons. It went from eight percent in 2016 to 9.5, 9.7, and 12.8 percent from 2017-19. Needless to say the Mets are hoping that trend starts heading in the other direction next season.